131 related articles for article (PubMed ID: 19189681)
21. Growth hormone receptor deficiency in humans associates to obesity, increased body fat percentage, a healthy brain and a coordinated insulin sensitivity.
Guevara-Aguirre J; Teran E; Lescano D; Guevara A; Guevara C; Longo V; Gavilanes AWD
Growth Horm IGF Res; 2020 Apr; 51():58-64. PubMed ID: 32145513
[TBL] [Abstract][Full Text] [Related]
22. [Analysis of clinical manifestations and genetic mutations in a child with Laron syndrome].
Chang GY; Chen SK; Gu XF; Gong ZW; Zhang QG
Zhonghua Er Ke Za Zhi; 2013 Dec; 51(12):930-3. PubMed ID: 24495765
[TBL] [Abstract][Full Text] [Related]
23. Endocrine assessment, molecular characterization and treatment of growth hormone insensitivity disorders.
Savage MO; Attie KM; David A; Metherell LA; Clark AJ; Camacho-Hübner C
Nat Clin Pract Endocrinol Metab; 2006 Jul; 2(7):395-407. PubMed ID: 16932322
[TBL] [Abstract][Full Text] [Related]
24. Identification of a novel mutation in the human growth hormone receptor gene (GHR) in a patient with Laron syndrome.
Gennero I; Edouard T; Rashad M; Bieth E; Conte-Aurio F; Marin F; Tauber M; Salles JP; El Kholy M
J Pediatr Endocrinol Metab; 2007 Jul; 20(7):825-31. PubMed ID: 17849745
[TBL] [Abstract][Full Text] [Related]
25. Obesity, diabetes and cancer: insight into the relationship from a cohort with growth hormone receptor deficiency.
Guevara-Aguirre J; Rosenbloom AL
Diabetologia; 2015 Jan; 58(1):37-42. PubMed ID: 25316432
[TBL] [Abstract][Full Text] [Related]
26. Growth hormone receptor sequence changes do not play a role in determining height in children with idiopathic short stature.
Hujeirat Y; Hess O; Shalev S; Tenenbaum-Rakover Y
Horm Res; 2006; 65(4):210-6. PubMed ID: 16582564
[TBL] [Abstract][Full Text] [Related]
27. Joseph Boruwlaski (1739-1837): a case of Laron syndrome?
Bauduer F
Med Hypotheses; 2014 Dec; 83(6):844-5. PubMed ID: 25459152
[No Abstract] [Full Text] [Related]
28. Short stature and decreased insulin-like growth factor I (IGF-I)/growth hormone (GH)-ratio in an adult GH-deficient patient pointing to additional partial GH insensitivity due to a R179C mutation of the growth hormone receptor.
Meyer S; Ipek M; Keth A; Minnemann T; von Mach MA; Weise A; Ittner JR; Nawroth PP; Plöckinger U; Stalla GK; Tuschy U; Weber MM; Kann PH; ;
Growth Horm IGF Res; 2007 Aug; 17(4):307-14. PubMed ID: 17462934
[TBL] [Abstract][Full Text] [Related]
29. A novel growth hormone receptor gene deletion mutation in a patient with primary growth hormone insensitivity syndrome (Laron syndrome).
Yamamoto H; Kouhara H; Iida K; Chihara K; Kasayama S
Growth Horm IGF Res; 2008 Apr; 18(2):136-42. PubMed ID: 17728167
[TBL] [Abstract][Full Text] [Related]
30. Fifty seven years of follow-up of the Israeli cohort of Laron Syndrome patients-From discovery to treatment.
Laron Z; Kauli R
Growth Horm IGF Res; 2016 Jun; 28():53-6. PubMed ID: 26307357
[TBL] [Abstract][Full Text] [Related]
31. Genetic Competencies for Effective Pediatric Endocrine Nursing Practice.
Davies K; Dwyer AA
J Pediatr Nurs; 2019; 48():127-128. PubMed ID: 31409498
[No Abstract] [Full Text] [Related]
32. [New molecular mechanisms of growth hormone insensitivity].
Edouard T; Raynal P; Yart A; Conte-Auriol F; Salles JP; Tauber M
Arch Pediatr; 2008 Feb; 15(2):179-88. PubMed ID: 18207712
[TBL] [Abstract][Full Text] [Related]
33. Growth Hormone Receptor Mutations Related to Individual Dwarfism.
Lin S; Li C; Li C; Zhang X
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29748515
[TBL] [Abstract][Full Text] [Related]
34. A novel mutation of exon 7 in growth hormone receptor mRNA in a patient with growth hormone insensitivity syndrome and neurofibromatosis type I.
Kang JH; Kim OS; Kim JH; Lee SK; Park YJ; Baik HW
Int J Mol Med; 2012 Sep; 30(3):713-7. PubMed ID: 22751808
[TBL] [Abstract][Full Text] [Related]
35. Compound heterozygosity for two GHR missense mutations in a patient affected by Laron Syndrome: a case report.
Moia S; Tessaris D; Einaudi S; de Sanctis L; Bona G; Bellone S; Prodam F
Ital J Pediatr; 2017 Oct; 43(1):94. PubMed ID: 29025428
[TBL] [Abstract][Full Text] [Related]
36. Clinical and Molecular Features of Laron Syndrome, A Genetic Disorder Protecting from Cancer.
Janecka A; Kołodziej-Rzepa M; Biesaga B
In Vivo; 2016; 30(4):375-81. PubMed ID: 27381597
[TBL] [Abstract][Full Text] [Related]
37. Brain Structure and Function Associated with Younger Adults in Growth Hormone Receptor-Deficient Humans.
Nashiro K; Guevara-Aguirre J; Braskie MN; Hafzalla GW; Velasco R; Balasubramanian P; Wei M; Thompson PM; Mather M; Nelson MD; Guevara A; Teran E; Longo VD
J Neurosci; 2017 Feb; 37(7):1696-1707. PubMed ID: 28073935
[TBL] [Abstract][Full Text] [Related]
38. Obese adults with primary growth hormone resistance (Laron Syndrome) have normal endothelial function.
Shechter M; Ginsberg S; Scheinowitz M; Feinberg MS; Laron Z
Growth Horm IGF Res; 2007 Apr; 17(2):165-70. PubMed ID: 17320443
[TBL] [Abstract][Full Text] [Related]
39. A novel exonic GHR splicing mutation (c.784G > C) in a patient with classical growth hormone insensitivity syndrome.
Akıncı A; Rosenfeld RG; Hwa V
Horm Res Paediatr; 2013; 79(1):32-8. PubMed ID: 23006617
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic and therapeutic advances in growth hormone insensitivity.
David A; Metherell LA; Clark AJ; Camacho-Hübner C; Savage MO
Endocrinol Metab Clin North Am; 2005 Sep; 34(3):581-95, viii. PubMed ID: 16085161
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
